August 11th, 2023

P10, Inc. (NYSE: PX), a technology solutions company specializing in innovative software applications, reported second-quarter 2023 earnings of $0.22 per share, surpassing the consensus EPS estimate of $0.18. The company's quarterly sales reached $62. Read more

August 10th, 2023

Shares of Archer Aviation Inc. (NYSE: ACHR) surged over 20% in after-hours trading on the back of significant developments. The company secured a substantial equity investment of $215 million from notable industry giants including Stellantis (NYSE: S. Read more

August 10th, 2023

Bittrex Global GmbH also settles charges for failing to register as a national securities exchange FOR IMMEDIATE RELEASE 2023-150 Washington D.C. / CRWE PRESS RELEASE / Aug. 10, 2023 -  The Securities and Exchange Commission today an. Read more

August 10th, 2023

Holley Inc. (NYSE: HLLY), a leading manufacturer of high-performance automotive components, reported second-quarter 2023 earnings of $0.14 per share, surpassing the consensus EPS estimate of $0.06. The company's quarterly sales reached $175.26 millio. Read more

August 10th, 2023

Edible Garden AG Incorporated (Nasdaq: EDBL), a provider of fresh herbs and produce, reported a second-quarter 2023 loss of $(0.24) per share, better than the consensus estimate loss of $(0.90). The company's quarterly sales amounted to $4.22 million. Read more

August 10th, 2023

Alibaba Group Holding Limited (NYSE: BABA), a global technology and e-commerce giant, reported first-quarter fiscal-year 2024 earnings of $2.40 per share, surpassing the consensus EPS estimate of $2.02. The company's quarterly sales stood at $32.29 b. Read more

August 10th, 2023

Shares of Vistagen Therapeutics, Inc. (Nasdaq: VTGN) surged over 20% in after-hours trading as Commodore Capital LP disclosed in a regulatory filing (Form 4) with the SEC that it has recently acquired 775,756 shares of Vistagen through multiple trans. Read more

August 09th, 2023

AppLovin Corporation (Nasdaq: APP) reported second quarter 2023 earnings of $0.22 per share, surpassing the consensus EPS estimate of $0.07. Additionally, the company achieved quarterly sales of $750.16 million, exceeding the analysts' forecasted rev. Read more

August 09th, 2023

Shares of Galera Therapeutics, Inc.? (Nasdaq: GRTX) plunged over 70% in after-hours trading as the company received a Complete Response Letter (CRL) from the FDA, addressing its New Drug Application (NDA) for avasopasem manganese, a potential treatme. Read more

August 09th, 2023

In a strategic move to bolster cybersecurity, the Biden-Harris Administration has introduced the "AI Cyber Challenge" (AIxCC), a two-year competition focused on fortifying critical software using artificial intelligence (AI). Led by DARPA and joined . Read more